Sympathetic mechanisms, organ damage, and antihypertensive treatment

Guido Grassi, Gino Seravalle, Raffaella Dell'Oro, Giuseppe Mancia

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Sympathetic activation characterizes essential hypertension, contributing to the development and progression of the high blood pressure state. Throughout the years, evidencehas been accumulated to show that adrenergic overdrive also participates in the pathogenesis of the endorgan damage associated with hypertension, including cardiac hypertrophy, left ventricular diastolic dysfunction, and heart failure, as well as the vascular structural and functional alterations that frequently can be detected in large, medium-size, andsmall arteries. Adrenergic overdrive also participates in the renal insufficiency and failure that may accompany the clinical course of the hypertensive state. This paper review evidence collected over the past few years documenting the importance of neurogenic factors in the development and progression of end-organ damage. The therapeutic implications of this evidence are also highlighted.

Original languageEnglish
Pages (from-to)303-308
Number of pages6
JournalCurrent Hypertension Reports
Volume13
Issue number4
DOIs
Publication statusPublished - Aug 2011

Fingerprint

Adrenergic Agents
Antihypertensive Agents
Renal Insufficiency
Diastolic Heart Failure
Hypertension
Cardiomegaly
Left Ventricular Dysfunction
Blood Vessels
Arteries
Therapeutics
Essential Hypertension

Keywords

  • Antihypertensive treatment
  • Hypertension
  • Sympathetic nervous system
  • Target organ damage

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Sympathetic mechanisms, organ damage, and antihypertensive treatment. / Grassi, Guido; Seravalle, Gino; Dell'Oro, Raffaella; Mancia, Giuseppe.

In: Current Hypertension Reports, Vol. 13, No. 4, 08.2011, p. 303-308.

Research output: Contribution to journalArticle

Grassi, Guido ; Seravalle, Gino ; Dell'Oro, Raffaella ; Mancia, Giuseppe. / Sympathetic mechanisms, organ damage, and antihypertensive treatment. In: Current Hypertension Reports. 2011 ; Vol. 13, No. 4. pp. 303-308.
@article{35ff4368c5b747e3bb8e3da41c979cae,
title = "Sympathetic mechanisms, organ damage, and antihypertensive treatment",
abstract = "Sympathetic activation characterizes essential hypertension, contributing to the development and progression of the high blood pressure state. Throughout the years, evidencehas been accumulated to show that adrenergic overdrive also participates in the pathogenesis of the endorgan damage associated with hypertension, including cardiac hypertrophy, left ventricular diastolic dysfunction, and heart failure, as well as the vascular structural and functional alterations that frequently can be detected in large, medium-size, andsmall arteries. Adrenergic overdrive also participates in the renal insufficiency and failure that may accompany the clinical course of the hypertensive state. This paper review evidence collected over the past few years documenting the importance of neurogenic factors in the development and progression of end-organ damage. The therapeutic implications of this evidence are also highlighted.",
keywords = "Antihypertensive treatment, Hypertension, Sympathetic nervous system, Target organ damage",
author = "Guido Grassi and Gino Seravalle and Raffaella Dell'Oro and Giuseppe Mancia",
year = "2011",
month = "8",
doi = "10.1007/s11906-011-0200-4",
language = "English",
volume = "13",
pages = "303--308",
journal = "Current Hypertension Reports",
issn = "1522-6417",
publisher = "Current Medicine Group",
number = "4",

}

TY - JOUR

T1 - Sympathetic mechanisms, organ damage, and antihypertensive treatment

AU - Grassi, Guido

AU - Seravalle, Gino

AU - Dell'Oro, Raffaella

AU - Mancia, Giuseppe

PY - 2011/8

Y1 - 2011/8

N2 - Sympathetic activation characterizes essential hypertension, contributing to the development and progression of the high blood pressure state. Throughout the years, evidencehas been accumulated to show that adrenergic overdrive also participates in the pathogenesis of the endorgan damage associated with hypertension, including cardiac hypertrophy, left ventricular diastolic dysfunction, and heart failure, as well as the vascular structural and functional alterations that frequently can be detected in large, medium-size, andsmall arteries. Adrenergic overdrive also participates in the renal insufficiency and failure that may accompany the clinical course of the hypertensive state. This paper review evidence collected over the past few years documenting the importance of neurogenic factors in the development and progression of end-organ damage. The therapeutic implications of this evidence are also highlighted.

AB - Sympathetic activation characterizes essential hypertension, contributing to the development and progression of the high blood pressure state. Throughout the years, evidencehas been accumulated to show that adrenergic overdrive also participates in the pathogenesis of the endorgan damage associated with hypertension, including cardiac hypertrophy, left ventricular diastolic dysfunction, and heart failure, as well as the vascular structural and functional alterations that frequently can be detected in large, medium-size, andsmall arteries. Adrenergic overdrive also participates in the renal insufficiency and failure that may accompany the clinical course of the hypertensive state. This paper review evidence collected over the past few years documenting the importance of neurogenic factors in the development and progression of end-organ damage. The therapeutic implications of this evidence are also highlighted.

KW - Antihypertensive treatment

KW - Hypertension

KW - Sympathetic nervous system

KW - Target organ damage

UR - http://www.scopus.com/inward/record.url?scp=80052575803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052575803&partnerID=8YFLogxK

U2 - 10.1007/s11906-011-0200-4

DO - 10.1007/s11906-011-0200-4

M3 - Article

VL - 13

SP - 303

EP - 308

JO - Current Hypertension Reports

JF - Current Hypertension Reports

SN - 1522-6417

IS - 4

ER -